-
Didn't make it to
#ABClisbon last Nov, don't worry!! on 23rd Jan at 18:15 Dr Fatima Cardoso &@curijoey will look at the highlights from what was a very successful ESO-ESMO Advanced Breast Cancer Fifth International Consensus Conference http://bit.ly/2G4DSjB#bcsm#oncoalertpic.twitter.com/2O0yHmBWeI
-
If you missed
#ABClisbon or would like to take a look at a presentation you particularly enjoyed then you can view all the available presentations here http://bit.ly/2L92VVB#bcsm#oncoalertpic.twitter.com/qfJzrrC3ER
-
Dear Colleagues, Fresh from
#ABCLisbon our colleague@BenedettaConte5
from @SanMartino_Ge
speaks to @OncoAlert
about her presentation at ABC5 on 2nd line T-DM1 after dual HER2 blockade in advanced #breastcancer
Best,
#OncoAlert
pic.twitter.com/2rDpW6vwjV -
Honoured to have been nominated but now I’ve won the catagory! Thank you so much & am looking forward to the event next week!
#BusyLivingWithMets#IWC19#GMCC2019@METUPUKorg#bccww#ABCLisbon#secondarybreastcancer#advancedbreastcancer#abcdretreat#sbcInfographichttps://twitter.com/WmnChangemakers/status/1196467414692745216 … -
We were glad to participate in the 2019
#ABCLisbon conference in Portugal. Many new things learned from the impressive lineup of speakers & facilitators. Thanks to@ESOncology and@ABCGlobalAll for putting together an impactful programme.@uicc#CancerAwarepic.twitter.com/zoQgstLAmd
-
Overall survival needs to be measured in
#clinicaltrial design. Strongly fought by Pharma because clinical benefits may not prove statistical significant. People with metastatic cancer want to live longer with quality of life.#bcsm#MetastaticBC#lcsm#amsm#ABCLisbon

https://twitter.com/christeeny513/status/1195006007237398529 …
-
A great pleasure to have caught up w/our amazing
@OncoAlert
colleague Kelly Shanahan @stage4kelly at#ABCLisbon who talked to us about the importance of the collaboration and exchange between Oncologists, Patient advocates and Oncology Nurses
We are ALL #OncoAlert
pic.twitter.com/yso0MdlDB5 -
It’s been a wonderful conference-
#ABCLisbon! Just hoping to get my voice back by#SABCS19!!
https://twitter.com/OncoAlert/status/1195709608372981762 …
-
ABC5 consensus guidelines session this morning
#ABCLisbon first 2 hours have been dedicated guidelines for patients with ER+, HER2 - tumors. Back 6 years ago the votes for this group took <1/2 hour. What an improvement in terms of treatment options for your patients!!! pic.twitter.com/ySjWsl0XMU
-
Such an honour to be part of the panel of the ABC 5 consensus meeting
#ABClisbon pic.twitter.com/b0k3RumQVC
-
.
@CancerworldESO and ESMO International Consensus Guidelines for Advanced#BreastCancer session starting now at#ABCLisbon#bcsmpic.twitter.com/crvbac1r0g
-
How much time have I got, Doc? "Best, Worst, and Typical Cancer Survival"--a proposed new framework for estimates. Katherine O'Brien, a patient advocate w/ metastatic breast cancer, reports from
#ABCLisbon conference,@Medscape https://www.medscape.com/viewarticle/921425 …@ihatebreastcanc#bcsm -
#ABCLisbon A great and simple idea for estimating cancer survival -- excellent first contribution to@Medscape from journalist Katherine O'Brien@ihatebreastcanc https://wb.md/2CNJJYN -
An underlining message from several speakers at
#ABCLisbon today: we are going to change how we define HER2 in breast cancer in the next few years, starting from thinking of HER2-low beyond HER2 positive/negative!@prat_aleix@PenaultLlorca@ESOncology -
Experience the
#MyTimeOurTime#MTOTArtivism artistic campaign and learn more about the interpretative work created by@sara_herranz at#ABCLisbon to give a voice to those living with#advancedbreastcancer.#ABCpic.twitter.com/uglMJptK6z
-
Lesley Fallowfield asked a great question at
#ABCLisbon - should pharma be mandated to spend 0.00000001% (or something of that order!) on research into drugs that treat the many side effects of the drugs they develop for MBC.#busylivingwithmets@METUPUKorg@abcdiagnosis -
Do you think new biomarkers will change the way we classify breast cancer in the near future? Prof
@prat_aleix with his great presentation at#ABCLisbon conference made me think this is likely to happen soon, expecially in HER2-positive breast cancer.#ABCLisbon pic.twitter.com/aQr9VHT8o5
-
Dr. Benedetta Conte
@BenedettaConte5 presenting at ABC @ESOncology conference in Lisbon the results of GIM14 TDM1 after trastu-pertuzumab in HER2+ disease#ABCLisbon Great job! pic.twitter.com/Akd0FcxbDd
-
such an important point and without including patients in clinical trial design, we may not be designing trials to best answer the questions and address issues that are most important to patients
#bcsm#ABCLisbon https://twitter.com/christeeny513/status/1195006007237398529 …
-
The Invisible Woman installation combines the power of visual interaction with patient storytelling to bring into focus the everyday reality of women living with
#advancedbreastcancer.#ABCLisbon#MyTimeOurTimepic.twitter.com/sWuUd1ZwSC
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
for taking the time to promote and disseminate knowledge that helps us in the fight against